Katie Abouzahr, MD

Vice president of Autoantibody and Maternal Fetal Immunology Disease Area Leader at Johnson & Johnson.

Articles by Katie Abouzahr, MD

Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD

Published: May 6th 2024 | Updated: May 6th 2024

The vice president, Autoantibody Portfolio and Maternal Fetal Immunology Disease Area Leader, Johnson & Johnson, provided perspective on the unique molecular structure of nipocalimab seen across nonclinical and clinical studies. [WATCH TIME: 3 minutes]

Latest Updated Articles

Katie Abouzahr, MD

Articles by Katie Abouzahr, MD

Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Differentiating Pathologic Features of Alzheimer Disease and Lewy Body Dementia: Charbel Moussa, MBBS, PhD

Improving Recognition and Treatment of Hyperkinetic Movement Disorders: Zoltan Mari, MD

Donanemab Shows Durable Amyloid Clearance and Consistent Safety in Early-Start Patients

Current and Emerging Strategies for Managing Huntington Disease Symptoms: Karen Anderson, MD

Improving Stability with Advanced Therapies in Parkinson’s Disease